5FR Stock Overview
Manufactures and sells contact lenses and lens care products. More details
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 1/6 |
| Past Performance | 2/6 |
| Financial Health | 4/6 |
| Dividends | 2/6 |
Menicon Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | JP¥9.35 |
| 52 Week High | JP¥15.20 |
| 52 Week Low | JP¥6.60 |
| Beta | 0.27 |
| 11 Month Change | 0.54% |
| 3 Month Change | 16.88% |
| 1 Year Change | -26.38% |
| 33 Year Change | -68.62% |
| 5 Year Change | n/a |
| Change since IPO | -54.17% |
Recent News & Updates
Recent updates
Shareholder Returns
| 5FR | DE Medical Equipment | DE Market | |
|---|---|---|---|
| 7D | -6.0% | -2.5% | -1.3% |
| 1Y | -26.4% | -8.4% | 7.4% |
Return vs Industry: 5FR underperformed the German Medical Equipment industry which returned -7.1% over the past year.
Return vs Market: 5FR underperformed the German Market which returned 7.1% over the past year.
Price Volatility
| 5FR volatility | |
|---|---|
| 5FR Average Weekly Movement | 4.3% |
| Medical Equipment Industry Average Movement | 5.2% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in DE Market | 10.8% |
| 10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: 5FR has not had significant price volatility in the past 3 months compared to the German market.
Volatility Over Time: 5FR's weekly volatility (4%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1943 | 4,221 | Hidenari Tanaka | www.menicon.co.jp |
Menicon Co., Ltd. manufactures and sells contact lenses and lens care products. The company offers its products to hospitals, ophthalmology clinics, contact lens stores, eyeglass stores, and drug stores. It exports its products in 80 countries, including the United States, Europe, Oceania, and Asia.
Menicon Co., Ltd. Fundamentals Summary
| 5FR fundamental statistics | |
|---|---|
| Market cap | €728.28m |
| Earnings (TTM) | €29.88m |
| Revenue (TTM) | €732.53m |
24.4x
P/E Ratio1.0x
P/S RatioIs 5FR overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 5FR income statement (TTM) | |
|---|---|
| Revenue | JP¥118.64b |
| Cost of Revenue | JP¥55.28b |
| Gross Profit | JP¥63.36b |
| Other Expenses | JP¥58.52b |
| Earnings | JP¥4.84b |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
Feb 14, 2025
| Earnings per share (EPS) | 63.80 |
| Gross Margin | 53.41% |
| Net Profit Margin | 4.08% |
| Debt/Equity Ratio | 76.0% |
How did 5FR perform over the long term?
See historical performance and comparisonDividends
1.8%
Current Dividend Yield39%
Payout RatioDoes 5FR pay a reliable dividends?
See 5FR dividend history and benchmarks| Menicon dividend dates | |
|---|---|
| Ex Dividend Date | Mar 28 2025 |
| Dividend Pay Date | Jun 27 2025 |
| Days until Ex dividend | 126 days |
| Days until Dividend pay date | 217 days |
Does 5FR pay a reliable dividends?
See 5FR dividend history and benchmarks